Influenza vaccine effectiveness in Europe and the birth cohort effect against influenza A(H1N1)pdm09: VEBIS primary care multicentre study, 2023/24

Esther Kissling, Silke Buda(Robert Koch Institute), S. Filipović(Hrvatski zavod za javno zdravstvo), Mariëtte Hooiveld(Netherlands Institute for Health Services Research), Mihaela Lazăr, Lisa Domegan(Health Service Executive), Marlena Kaczmarek(European Centre for Disease Prevention and Control), Alina Elena Ivanciuc, Shirley Masse(Inserm), Marine Maurel, Verónica Gomez(National Institute of Health Dr. Ricardo Jorge), Gergő Túri(Semmelweis University), Tove Samuelsson Hagey(Public Health Agency of Sweden), Gloria Pérez‐Gimeno(Instituto de Salud Carlos III), Ana Paula Rodrigues(Microsoft (Brazil)), Vincent Enouf(Université Claude Bernard Lyon 1), Adam Meijer(National Centre for Infectious Diseases), Beatrix Oroszi, Francisco Pozo(Instituto de Salud Carlos III), Ralf Dürrwald(IDT Biologika (Germany)), Sabrina Bacci(European Centre for Disease Prevention and Control), Charlene Bennett(University College Dublin), Vesna Višekruna Vučina(Hrvatski zavod za javno zdravstvo), Neus Latorre‐Margalef(Public Health Agency of Sweden), Camino Trobajo‐Sanmartín(Instituto de Salud Pública de Navarra), Jaume Giménez Durán, Noémie Sève(Inserm), Iván Martínez‐Baz(Instituto de Salud Carlos III), Miriam García Vázquez, Jesús Castilla(Instituto de Salud Pública de Navarra), Raquel Guiomar(National Institute of Health Dr. Ricardo Jorge), Adele McKenna(Health Protection Surveillance Centre), Marit de Lange(National Institute for Public Health and the Environment), Annika Erdwiens(Robert Koch Institute), Ivan Mlinarić(Hrvatski zavod za javno zdravstvo), Koloman Krištof(Semmelweis University)
Eurosurveillance
June 12, 2025
Cited by 9


Related Papers